NL7205573A - - Google Patents
Info
- Publication number
- NL7205573A NL7205573A NL7205573A NL7205573A NL7205573A NL 7205573 A NL7205573 A NL 7205573A NL 7205573 A NL7205573 A NL 7205573A NL 7205573 A NL7205573 A NL 7205573A NL 7205573 A NL7205573 A NL 7205573A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU63060 | 1971-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7205573A true NL7205573A (pt) | 1972-10-30 |
Family
ID=19726690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7205573A NL7205573A (pt) | 1971-04-26 | 1972-04-25 |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH540695A (pt) |
| DE (1) | DE2220504A1 (pt) |
| FR (1) | FR2134503B1 (pt) |
| GB (1) | GB1358001A (pt) |
| LU (1) | LU63060A1 (pt) |
| NL (1) | NL7205573A (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9103110D0 (sv) | 1991-10-24 | 1991-10-24 | Kabi Pharmacia Ab | New drug formulation |
| WO2000040224A1 (en) * | 1999-01-07 | 2000-07-13 | Elan Corporation, Plc | Multiparticulate oral dosage forms |
| CA2645855C (en) | 2006-03-16 | 2015-02-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| BR112015003120B1 (pt) | 2012-08-15 | 2022-08-09 | Tris Pharma , Inc | Tablete mastigável de liberação estendida de metilfenidato e seu uso |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7017E (pt) * | ||||
| BE560809A (pt) * |
-
1971
- 1971-04-26 LU LU63060D patent/LU63060A1/xx unknown
-
1972
- 1972-04-21 CH CH598872A patent/CH540695A/fr not_active IP Right Cessation
- 1972-04-25 NL NL7205573A patent/NL7205573A/xx unknown
- 1972-04-25 FR FR7214686A patent/FR2134503B1/fr not_active Expired
- 1972-04-26 GB GB1928372A patent/GB1358001A/en not_active Expired
- 1972-04-26 DE DE2220504A patent/DE2220504A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| LU63060A1 (pt) | 1971-08-26 |
| GB1358001A (en) | 1974-06-26 |
| DE2220504A1 (de) | 1973-02-15 |
| CH540695A (fr) | 1973-08-31 |
| FR2134503A1 (pt) | 1972-12-08 |
| FR2134503B1 (pt) | 1976-07-02 |